Three drug makers seek bigger market share

Published: 2007-05-22 06:59:00

Updated: 2007-05-22 06:59:00

Three pharmaceutical firms SK Chemical, Pacific Pharm and Jeil Pharm are gearing up to boost its marketing activities in the domestic cataplaster market showing a sluggish trend, apparently perturbed by growing number of doctors who avoid prescribing cataplasters in fear of non-reimbursement.
...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK